Tumor immunology.
Stevenson
H
H
Biologics Evaluation Section, National Cancer Institute, National Institutes of Health, Rockville, Maryland.
Tsang
K Y
KY
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000912:Antibodies, Neoplasm / Q000276:immunology; D000951:Antigens, Neoplasm / Q000235:genetics / Q000276:immunology; D014408:Biomarkers, Tumor; D001781:Blood Component Removal; D002471:Cell Transformation, Neoplastic; D016147:Genes, Tumor Suppressor; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D016233:Immunotherapy, Active; D016219:Immunotherapy, Adoptive; D016131:Lymphocyte Subsets / Q000276:immunology; D009363:Neoplasm Proteins / Q000276:immunology; D009369:Neoplasms / Q000235:genetics / Q000276:immunology* / Q000628:therapy; D009857:Oncogenes
D000276:Adjuvants, Immunologic; D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D007155:Immunologic Factors; D009363:Neoplasm Proteins